Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Expert Opinion on Therapeutic Targets
|
July 5, 2005
The emerging utility of animal models of chronic neurodegenerative diseases
P J Kahle, C Haass
Journal of Neuroscience Research
|
May 20, 1998
Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro
S Horstmann, P J Kahle, G D Borasio
Neuroscience
|
March 11, 2009
Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice
H Schell, T Hasegawa, M Neumann, et al.
Laboratory Animal Science
|
September 10, 1999
Neurons and mechanisms of neuronal death in neurodegenerative diseases: a brief review
K S Waggie, P J Kahle, R J Tolwani
Annals of the New York Academy of Sciences
|
February 24, 2001
Physiology and pathophysiology of alpha-synuclein. Cell culture and transgenic animal models based on a Parkinson's disease-associated protein
P J Kahle, M Neumann, L Ozmen, et al.
The Journal of Biological Chemistry
|
November 20, 1997
The role of the nerve growth factor carboxyl terminus in receptor binding and conformational stability
A Krüttgen, J V Heymach, P J Kahle, et al.
Cellular Signalling
|
August 6, 1998
Phosphatidylcholine-specific phospholipase inhibitor D609 differentially affects MAP kinases and immediate-early genes in PC12 cells
P J Kahle, E M Shooter, R M Johnson, et al.
Neurobiology of Disease
|
January 1, 1997
Survival-promoting activity of inhibitors of cyclin-dependent kinases on primary neurons correlates with inhibition of c-Jun kinase-1
M A Markus, P J Kahle, A Winkler, et al.
Journal of Neurochemistry
|
April 2, 1998
Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors
J W Maas, S Horstmann, G D Borasio, et al.
The Journal of Biological Chemistry
|
January 5, 2000
Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein
M Okochi, J Walter, A Koyama, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Expert Opinion on Therapeutic Targets
|
July 5, 2005
The emerging utility of animal models of chronic neurodegenerative diseases
P J Kahle, C Haass
Journal of Neuroscience Research
|
May 20, 1998
Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro
S Horstmann, P J Kahle, G D Borasio
Neuroscience
|
March 11, 2009
Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice
H Schell, T Hasegawa, M Neumann, et al.
Laboratory Animal Science
|
September 10, 1999
Neurons and mechanisms of neuronal death in neurodegenerative diseases: a brief review
K S Waggie, P J Kahle, R J Tolwani
Annals of the New York Academy of Sciences
|
February 24, 2001
Physiology and pathophysiology of alpha-synuclein. Cell culture and transgenic animal models based on a Parkinson's disease-associated protein
P J Kahle, M Neumann, L Ozmen, et al.
The Journal of Biological Chemistry
|
November 20, 1997
The role of the nerve growth factor carboxyl terminus in receptor binding and conformational stability
A Krüttgen, J V Heymach, P J Kahle, et al.
Cellular Signalling
|
August 6, 1998
Phosphatidylcholine-specific phospholipase inhibitor D609 differentially affects MAP kinases and immediate-early genes in PC12 cells
P J Kahle, E M Shooter, R M Johnson, et al.
Neurobiology of Disease
|
January 1, 1997
Survival-promoting activity of inhibitors of cyclin-dependent kinases on primary neurons correlates with inhibition of c-Jun kinase-1
M A Markus, P J Kahle, A Winkler, et al.
Journal of Neurochemistry
|
April 2, 1998
Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors
J W Maas, S Horstmann, G D Borasio, et al.
The Journal of Biological Chemistry
|
January 5, 2000
Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein
M Okochi, J Walter, A Koyama, et al.
Page
of 3